Jang Hwan Kim

Jang Hwan Kim

Auto-generated profile, based on publicly available information

Jang Hwan Kim

Department of Urology and Urological Science Institute, Yonsei University College of Medicine, Seoul, Korea

Research Focus & Metrics

Academic Career Length

29Years (1998-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 March 2012 in Annals of Surgical Oncology
Verified
Journal Article
Closed access
PDF file
JKJeong Yeon Kim
Jeong Yeon Kim
NKNam Kyu Kim
Nam Kyu Kim
KLKang Young Lee
Kang Young Lee
HHHyuk Hur
Hyuk Hur
BMByung Soh Min
Byung Soh Min
JKJang Hwan Kim
Jang Hwan Kim

7 November 2005 in IEEE Transactions on Power Electronics
Verified
Journal Article
Open access
HRHyung-Min Ryu
Hyung-Min Ryu
JKJang-Hwan Kim
Jang-Hwan Kim
SSSeung-Ki Sul
Seung-Ki Sul
Multiphase motors are usually designed to have the concentrated winding and nonsinusoidal airgap flux density distribution in order to maximize the torque per ampere. This means that the phase voltage of a multiphase motor has the nonsinusoidal waveform. Accordingly, the conventional analysis on a multiphase space vector pulse-width modulation (SVPWM), which is confined to a sinusoidal phase voltage, should be extended to a nonsinusoidal phase voltage. In this paper, based on a multiple d-q spaces concept a novel analysis on a multiphase SVPWM to synthesize an arbitrary nonsinusoidal phase voltage is proposed. Throughout this paper, a five-phase inverter is used as a practical example. The basic concepts can be easily extended to an n-phase inverter.

1 May 2005 in Journal of Urology
Verified
Journal Article
Closed access
PDF file
NBNelson E. Bennett
Nelson E. Bennett
JKJang H. Kim
Jang H. Kim
DWDarren P. Wolfe
Darren P. Wolfe
KSKatsumi Sasaki
Katsumi Sasaki
NYNaoki Yoshimura
Naoki Yoshimura
MCMichael B. Chancellor
Michael B. Chancellor
Erectile dysfunction (ED) is a common but difficult to treat complication of diabetes mellitus (DM). We have previously reported herpes simplex virus (HSV) vector mediated delivery of nerve growth factor into the bladder to treat diabetic cystopathy and neurotrophin-3 (NT3) gene transfer for pyridoxine treatment. Nerve growth factor and NT3 are neurotrophic factors that may protect nerves from mechanical and metabolic damage. We investigated the effects of HSV mediated delivery of NT3 for the treatment of diabetic ED. Male Sprague-Dawley rats weighing 300 to 400 gm were injected with 65 mg/kg streptozotocin to induce DM. After 4 weeks 20 μl containing 5 × 108 pfu replication defective HSV vector expressing lacZ (6 rats) or NT3 (6) were injected directly into the cavernous nerve sheath with a 30 gauge needle. Four weeks later the animals underwent measurement of intracavernous pressure under electrical stimulation (20 Hz, 0.5 millisecond and 10 V) of the cavernous nerve. Staining for lacZ and neuronal nitric oxide synthase in the major pelvic ganglia was also performed. β-Galactosidase staining revealed lacZ positive neurons in the major pelvic ganglia. Maximal intracavernous pressure induced by electrical stimulation showed statistically significant mean values ± SEM of 15.1 ± 2.1 and 43.8 ± 11.1 cm H2O in the lacZ and NT3 vector injected groups, respectively (p = 0.03). The mean number of neuronal nitric oxide synthase positive neurons per section in the NT3 group was significantly higher than that in the lacZ control group at 3.33 ± 0.23 and 0.64 ± 0.14 neurons per high power field, respectively (p < 0.001). We report that gene therapy for the treatment of diabetic ED is feasible with HSV vectors. NT3 gene therapy may be applicable for the treatment of ED induced by DM.

1 May 2010 in Urology
Verified
Journal Article
Closed access
SLSeung-ryeol Lee
Seung-ryeol Lee
HKHyung Joon Kim
Hyung Joon Kim
AKAyoung Kim
Ayoung Kim
JKJang Hwan Kim
Jang Hwan Kim

26 July 2011 in Prostate Cancer and Prostatic Diseases
Verified
Journal Article
Open access
SLSeung Hwan Lee
Seung Hwan Lee
BCByung Ha Chung
Byung Ha Chung
SKS J Kim
S J Kim
JKJ H Kim
J H Kim
JKJ C Kim
J C Kim
JLJi Youl Lee
Ji Youl Lee
We aimed to evaluate the efficacy and safety of combination treatment using anticholinergics with α-blocker for initial treatment of both overactive bladder (OAB) and other lower urinary tract symptoms (LUTS), secondary to BPH. A 12-week, randomized, double-blind, placebo-controlled trial was conducted at four urology clinics in Korea, involving men, aged 50 years or older, with LUTS related to BPH and OAB. A total of 176 patients were randomly assigned to receive doxazosin (4 mg) plus placebo or doxazosin (4 mg) plus tolterodine SR (4 mg), once a day for 12 weeks. Changes from baseline in total International Prostate Symptom Score (IPSS), bladder diary variables, patient perception of bladder condition (PPBC), uroflowmetry, postvoid residual volume and IPSS subscores (voiding and storage) were analyzed. Of the 176 enrolled patients, 91 had doxazosin gastrointestinal therapeutic system (GITS) and placebo, and 85 had combined medication with doxazosin GITS and tolterodine SR. Compared with the doxazosin plus placebo group, the doxazosin plus tolterodine group showed significant reductions in IPSS storage subscore and improvement in the quality of life item, urgency episodes, as well as in micturition frequency at weeks 4 and 12. However, it failed to improve PPBC at week 4 as well as at week 12. Earlier intervention with anticholinergics plus α-blocker was tolerated well, including the questions about urinary retention (n=1) and dry mouth (n=2). Initial combination treatment of anticholinergics plus α-blocker showed positive results for men with LUTS related to BPH and OAB symptoms and did not increase the risk of urinary retention.